Navigation Links
Study Data Show Asacol(R) (Mesalamine) is Effective in Treating All Extents of Ulcerative Colitis Including Isolated Proctitis
Date:12/5/2007

Findings reinforce the benefits of Asacol for ulcerative colitis patients

AVENTURA, Fla., Dec. 5 /PRNewswire/ -- Data from two Phase III clinical trials support that Asacol, an oral, non-steroidal medication that belongs to the class of agents known as 5-aminosalicylic acids (5-ASAs), is an effective and well-tolerated treatment for patients with all extents of ulcerative colitis (UC), including isolated proctitis. The results showed that patients with isolated proctitis who took Asacol, dosed at 2.4 g/day for six weeks, experienced significant improvement as early as three weeks, and sustained improvement at six weeks, of UC symptoms. At six weeks 83 percent of patients had improvement in rectal bleeding, 75 percent had mucosal healing and 57 percent had reduced stool frequency. These data were presented today at the Crohn's & Colitis Foundation of America's (CCFA) National Research and Clinical Conference/Sixth Annual Advances in the Inflammatory Bowel Diseases (IBD) Meeting.

Treatment of UC patients is impacted by the fact that most patients would choose oral therapy over other routes of delivery, such as rectal therapy(1). However, approximately 30 percent of UC patients have isolated proctitis(2), a condition that is thought to be a challenge to treat with oral medication alone.

"A common misperception among physicians is that all oral 5-ASA studies have included proctitis patients; however, this is not the case," says Dr. Seymour Katz, Clinical Professor of Medicine at the New York University School of Medicine. "The positive findings from these Asacol studies reassure physicians that Asacol is one treatment that has been proven effective throughout the entire colon, even the most distal portions, and should help guide physicians how to effectively treat their UC patients."

Additional Study Details

Data from two Phase III, multi-center, randomized, double-blind, 6-week, active-controlled studies of similar design (ASCEND
'/>"/>

SOURCE Procter & Gamble Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
5. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
6. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
7. Study Suggests High-Dose Fish Oil May Significantly Improve Behavior in Children with ADHD
8. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
9. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
10. MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
11. Sarasotas Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... DALLAS , July 11, 2014 ... report "Scintillator Market by Composition of Material, Application ... and others), End Product (Personal Instrument, Hand-Held Instruments, ... Forecast and Analysis to 2013 - 2020", published by MarketsandMarkets, ... a CAGR of 5.62% from 2014 to 2020, ...
(Date:7/11/2014)... , July 11, 2014  Australian drug delivery company, ... it has raised A$19.3 million via a placement of ... , the U.S., Asia ... from a share purchase plan (SPP) to be offered ... be made in two tranches. "This capital ...
(Date:7/11/2014)... 2014 Research and Markets ( http://www.researchandmarkets.com/research/tjlw9k/immunoprotein ... "Immunoprotein Diagnostic Testing Market - Forecasts to 2019: ... 6% and is expected to be valued at ... http://photos.prnewswire.com/prnh/20130307/600769 ... been segmented according to immunoprotein types which include ...
Breaking Medicine Technology:Scintillator Market will be worth $479.16 Million by 2020 2Scintillator Market will be worth $479.16 Million by 2020 3Scintillator Market will be worth $479.16 Million by 2020 4Phosphagenics' A$19.3 million Capital Raising 2Phosphagenics' A$19.3 million Capital Raising 3Immunoprotein Diagnostic Testing Market - Forecasts to 2019: Expected to grow at the highest CAGR of 6% and is expected to be valued at USD 4,943.0 million 2
(Date:7/12/2014)... rise in the number of mobility devices around the ... suit the upsurge. Virtualization has become a growing trend ... The data traffic has increased by several folds with ... in larger and more complex networks. These global factors ... , The North American (NA) region is expected to ...
(Date:7/12/2014)... The "North American ... Market by Angioplasty Balloon (Plain/Old, Cutting), ... IVC Filter (Retrievable), Endovascular Stent Graft ... studies the major market drivers, restraints, ... Canada. , Browse 108 market data ...
(Date:7/12/2014)... July 12, 2014 The Security Analytics ... 2013 to $3,376.6 million by 2019, at an expected ... 2019. The challenges to counter the increasing number of ... of outdated cyber defense systems in organizations are enormous. ... and remodeling their existing architecture to develop better and ...
(Date:7/12/2014)... Casinos in Australia have ... from international and online casinos. Revenue is estimated to ... years through 2014-15. Greater per capita gambling expenditure has ... Rises in discretionary income levels have also assisted revenue ... items such as casino gambling services. Revenue is estimated ...
(Date:7/12/2014)... "The second toes cross over the big toes on ... said an inventor from East Hartford, Conn. This gave him ... , He then created a prototype of the Comfort Sock, ... big toes from overlapping. This avoids discomfort and pain, which ... to use, it's ideal for people with foot problems, athletes ...
Breaking Medicine News(10 mins):Health News:North America Software Defined Network (SDN) Market Worth $1,443.8 Million by 2019 - New Report by MicroMarket Monitor 2Health News:North America Software Defined Network (SDN) Market Worth $1,443.8 Million by 2019 - New Report by MicroMarket Monitor 3Health News:North America Software Defined Network (SDN) Market Worth $1,443.8 Million by 2019 - New Report by MicroMarket Monitor 4Health News:North America Software Defined Network (SDN) Market Worth $1,443.8 Million by 2019 - New Report by MicroMarket Monitor 5Health News:North American Interventional Cardiology & Peripheral Vascular Devices Market - New Report by MarketsandMarkets 2Health News:North American Interventional Cardiology & Peripheral Vascular Devices Market - New Report by MarketsandMarkets 3Health News:North American Interventional Cardiology & Peripheral Vascular Devices Market - New Report by MarketsandMarkets 4Health News:North American Interventional Cardiology & Peripheral Vascular Devices Market - New Report by MarketsandMarkets 5Health News:North America Security Analytics Market Worth $1,215.2 Million by 2019 - New Report by MicroMarket Monitor 2Health News:North America Security Analytics Market Worth $1,215.2 Million by 2019 - New Report by MicroMarket Monitor 3Health News:North America Security Analytics Market Worth $1,215.2 Million by 2019 - New Report by MicroMarket Monitor 4Health News:Casinos in Australia Industry Market Research Report Now Updated by IBISWorld 2Health News:Casinos in Australia Industry Market Research Report Now Updated by IBISWorld 3Health News:Casinos in Australia Industry Market Research Report Now Updated by IBISWorld 4
... , , , ... brush and the expression of dance and movement have an incredible ... as art therapy, dance and movement therapy and equine therapy, have ... issues including substance abuse, eating disorders, abuse issues, depression, anxiety, relationship ...
... , ALBANY, N.Y., July 31 ... New York throughout the week of August 3 - 7 ... New Yorkers access information on programs that provide prescription medicines for ... 8.2 percent, compared to 5.2 percent a year ago, the ...
... Healthy African American Families, Familia Unida and ... Practices that Deny California Communities Access ... LOS ANGELES, July 31 California patient advocacy organizations Healthy ... a letter to California Attorney General Jerry Brown requesting an ...
... coverage, for health effects, , FRIDAY, July 31 (HealthDay News) ... obesity in the United States have tripled, putting increasing numbers ... a new study. , Researchers looked at National Health and ... years, and found that the prevalence of severe obesity increased ...
... journal of the American Academy of Ophthalmology, reports on ... macular edema as well as people who develop cystoid ... to treat some cancers. Another study describes methods that ... patients. DR is the major threat to vision in ...
... Ohio, July 31 PharmaForce, Inc., announced today that it ... (FDA) for its Abbreviated New Drug Application (ANDA) for Betamethasone ... version of Schering Corporation,s Celestone(R) Soluspan(R). , , ... is marketed in a 6 mg/mL (3 mg base betamethasone/mL; ...
Cached Medicine News:Health News:The Healing Power of Art, Dance and Expression 2Health News:The Healing Power of Art, Dance and Expression 3Health News:Partnership for Prescription Assistance Prepared to Help New York Workers Hurt by Recession 2Health News:Partnership for Prescription Assistance Prepared to Help New York Workers Hurt by Recession 3Health News:Minority and Women's Advocacy Groups Send Letter to California Attorney General Jerry Brown Requesting Investigation Into Discrimination by Health Insurance Companies 2Health News:Minority and Women's Advocacy Groups Send Letter to California Attorney General Jerry Brown Requesting Investigation Into Discrimination by Health Insurance Companies 3Health News:Minority and Women's Advocacy Groups Send Letter to California Attorney General Jerry Brown Requesting Investigation Into Discrimination by Health Insurance Companies 4Health News:More Kids Becoming Severely Obese 2Health News:Cancer treatment controls macular edema related to diabetes and to cataract surgery 2Health News:Cancer treatment controls macular edema related to diabetes and to cataract surgery 3Health News:PharmaForce Inc. Receives FDA Approval for First Generic of Betamethasone Sodium Phosphate and Betamethasone Acetate Injectable Suspension, USP 2
Barkan Goniotomy Knife: 4" (11.4 cm), 2.5 mm blade....
... proven that the management of diabetes in order ... is the most effective way to reduce or ... at maintaining or improving a diabetes patients quality ... , ,These have been the guiding factors ...
... diabetes requires making decisions about insulin dosages ... These decisions are guided by data from ... and by the patterns that can be ... Providers when the data is presented in ...
... Photocoagulator - Portable and rugged solid-state photocoagulator ... and operating room. Built to high-duty cycle ... most demanding environments, the Novus Verdi can ... full line of accessories for private practice ...
Medicine Products: